Liaoning Medical DiagnosisTreatment Technology ResearchDevelopment Co.Ltd.
Autologous immune Cells(Liaoning Medical Diagnosis and Treatment Technology Research and Development Co., Ltd.)은 Lung Cancer (Locally Advanced or Metasta 표적 세포·유전자 치료로, Lung Cancer (Locally Advanced or Metastatic); Liver Cancer (Locally Advanced or Metastatic) 영역에서 개발·상용화 중입니다. 작용기전: checkpoint co-expression score correlated with both overall and contact-dependent tumor cell death. Phase 2에서 효능·안전성 신호를 검증 중입니다. OS: 16. 차별점: novel treatment approach aiming to increase precision and reduce toxicity compared with traditional immune checkpoint inhibit.
Lung Cancer (Locally Advanced or Metasta
Lung Cancer (Locally Advanced or Metastatic); Liver Cancer (Locally Advanced or Metastatic)
Recruiting
NK cell activation in MDOTS when combined with TGFβ and PD-1
design
Lentiviral vectors encoding murine or human IL6/1 were designed using Vector Builder and e
novel treatment approach aiming to increase precision and reduce toxicity compared with traditional immune checkpoint inhibit
checkpoint co-expression score correlated with both overall and contact-dependent tumor cell death
T-cell activation
apoptosis through soluble inflammatory mediators in a same-donor primary-cell system
biomarkers and therapeutic targets for investigating tumor-specific immune responses following locoregional t
downregulation of inflammation-related pathways, whereas another allogeneic donor strain induced a distinct transcriptional profile
차트 로드 중…
임상시험이 많습니다. 임상시험 탭에서 Phase/Status 필터·검색을 사용하세요.
수집된 임상 필드(phase, status, endpoint 등) 기반 자동 요약입니다.
Liaoning Medical DiagnosisTreatment Technology ResearchDevelopment Co.Ltd.
Autologous immune Cells(Liaoning Medical Diagnosis and Treatment Technology Research and Development Co., Ltd.)은 Lung Cancer (Locally Advanced or Metasta 표적 세포·유전자 치료로, Lung Cancer (Locally Advanced or Metastatic); Liver Cancer (Locally Advanced or Metastatic) 영역에서 개발·상용화 중입니다. 작용기전: checkpoint co-expression score correlated with both overall and contact-dependent tumor cell death. Phase 2에서 효능·안전성 신호를 검증 중입니다. OS: 16. 차별점: novel treatment approach aiming to increase precision and reduce toxicity compared with traditional immune checkpoint inhibit.
Lung Cancer (Locally Advanced or Metasta
Lung Cancer (Locally Advanced or Metastatic); Liver Cancer (Locally Advanced or Metastatic)
Recruiting
NK cell activation in MDOTS when combined with TGFβ and PD-1
design
Lentiviral vectors encoding murine or human IL6/1 were designed using Vector Builder and e
novel treatment approach aiming to increase precision and reduce toxicity compared with traditional immune checkpoint inhibit
checkpoint co-expression score correlated with both overall and contact-dependent tumor cell death
T-cell activation
apoptosis through soluble inflammatory mediators in a same-donor primary-cell system
biomarkers and therapeutic targets for investigating tumor-specific immune responses following locoregional t
downregulation of inflammation-related pathways, whereas another allogeneic donor strain induced a distinct transcriptional profile
차트 로드 중…
임상시험이 많습니다. 임상시험 탭에서 Phase/Status 필터·검색을 사용하세요.
수집된 임상 필드(phase, status, endpoint 등) 기반 자동 요약입니다.